Abciximab
The therapeutic efficacy of Abciximab can be decreased when used in combination with Dydrogesterone.
Acenocoumarol
The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Dydrogesterone.
Ancrod
The therapeutic efficacy of Ancrod can be decreased when used in combination with Dydrogesterone.
Advertisement
Antithrombin III
The therapeutic efficacy of Antithrombin III human can be decreased when used in combination with Dydrogesterone.
Antithrombin III, Human
The therapeutic efficacy of Antithrombin III human can be decreased when used in combination with Dydrogesterone.
Apixaban
The therapeutic efficacy of Apixaban can be decreased when used in combination with Dydrogesterone.
Advertisement
Ardeparin
The therapeutic efficacy of Ardeparin can be decreased when used in combination with Dydrogesterone.
Argatroban
The therapeutic efficacy of Argatroban can be decreased when used in combination with Dydrogesterone.
Argatroban Anhydrous
The therapeutic efficacy of Argatroban can be decreased when used in combination with Dydrogesterone.
Advertisement
Becaplermin
The therapeutic efficacy of Becaplermin can be decreased when used in combination with Dydrogesterone.
Bivalirudin
The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Dydrogesterone.
C1 esterase inhibitor (human)
Dydrogesterone may increase the thrombogenic activities of Human C1-esterase inhibitor.
C1 esterase inhibitor (recombinant)
Dydrogesterone may increase the thrombogenic activities of Conestat alfa.
Certoparin
The therapeutic efficacy of Certoparin can be decreased when used in combination with Dydrogesterone.
Citric Acid
The therapeutic efficacy of Citric Acid can be decreased when used in combination with Dydrogesterone.
Citric Acid, Anhydrous
The therapeutic efficacy of Citric Acid can be decreased when used in combination with Dydrogesterone.
Dabigatran Etexilate
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Dydrogesterone.
Dalteparin
The therapeutic efficacy of Dalteparin can be decreased when used in combination with Dydrogesterone.
Danaparoid
The therapeutic efficacy of Danaparoid can be decreased when used in combination with Dydrogesterone.
Desirudin
The therapeutic efficacy of Desirudin can be decreased when used in combination with Dydrogesterone.
Dextran
The therapeutic efficacy of Dextran can be decreased when used in combination with Dydrogesterone.
Dextran 40
The therapeutic efficacy of Dextran 40 can be decreased when used in combination with Dydrogesterone.
Dextran 70
The therapeutic efficacy of Dextran 70 can be decreased when used in combination with Dydrogesterone.
Dextran 75
The therapeutic efficacy of Dextran 75 can be decreased when used in combination with Dydrogesterone.
Dicumarol
The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Dydrogesterone.
Edetic Acid
The therapeutic efficacy of Edetic Acid can be decreased when used in combination with Dydrogesterone.
Edoxaban
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Dydrogesterone.
Enoxaparin
The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Dydrogesterone.
Enoxaparin sodium
The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Dydrogesterone.
Ethylenediaminetetraacetate
The therapeutic efficacy of Edetic Acid can be decreased when used in combination with Dydrogesterone.
Ferulic Acid
The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Dydrogesterone.
Fluindione
The therapeutic efficacy of Fluindione can be decreased when used in combination with Dydrogesterone.
Fondaparinux
The therapeutic efficacy of Fondaparinux can be decreased when used in combination with Dydrogesterone.
Fondaparinux sodium
The therapeutic efficacy of Fondaparinux sodium can be decreased when used in combination with Dydrogesterone.
Heparin
The therapeutic efficacy of Heparin can be decreased when used in combination with Dydrogesterone.
Lepirudin
The therapeutic efficacy of Lepirudin can be decreased when used in combination with Dydrogesterone.
Nadroparin
The therapeutic efficacy of Nadroparin can be decreased when used in combination with Dydrogesterone.
Pentaerythritol Tetranitrate
The therapeutic efficacy of Pentaerythritol Tetranitrate can be decreased when used in combination with Dydrogesterone.
Pentosan Polysulfate
The therapeutic efficacy of Pentosan Polysulfate can be decreased when used in combination with Dydrogesterone.
Phenindione
The therapeutic efficacy of Phenindione can be decreased when used in combination with Dydrogesterone.
Phenprocoumon
The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Dydrogesterone.
protein C, human
The therapeutic efficacy of Protein C can be decreased when used in combination with Dydrogesterone.
protein S, human
The therapeutic efficacy of Protein S human can be decreased when used in combination with Dydrogesterone.
Protocatechualdehyde
The therapeutic efficacy of Protocatechualdehyde can be decreased when used in combination with Dydrogesterone.
Reviparin
The therapeutic efficacy of Reviparin can be decreased when used in combination with Dydrogesterone.
Reviparin sodium
The therapeutic efficacy of Reviparin can be decreased when used in combination with Dydrogesterone.
Rivaroxaban
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Dydrogesterone.
Troxerutin
The therapeutic efficacy of Troxerutin can be decreased when used in combination with Dydrogesterone.
Ulipristal
The therapeutic efficacy of Dydrogesterone can be decreased when used in combination with Ulipristal.
Warfarin
The therapeutic efficacy of Warfarin can be decreased when used in combination with Dydrogesterone.
